When subgroup analysis was defined according to tumor stage, we found a statistically significant impact of IL-17 on unfavorable survival, revealing that this poor prognostic factor could be of importance not only in early-stage LC but also in advanced staged LC. The gene discussed is IL17A; the disease is neoplasm.